Mumbai, February 22, 2018: Pharma significant Lupin declared the dispatch of its Memantine Hydrochloride Broadened Discharge Containers, 7mg, 14mg, 21mg,28mg having gotten an endorsement from the Assembled States Sustenance and Medication Organization (FDA) prior.
Lupin’s Memantine Hydrochloride ER containers 7mg, 14mg, 21mg, 28mg are the nonexclusive counterparts of Allergan’s Namenda XR capsiles.
It is demonstrated for the treatment of direct to serious dementia of the Alzheimer’s write. Memantine Hydrochloride ER cases 7mg, 14mg, 21mg, 28mg had yearly offers of roughly USD 936 million in the US.
New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…